Evidence map›Paper›PMID 33963925›Full record

ArticleVirchows Archiv : an international journal of pathology2021

Prognostic relevance and putative histogenetic role of cytokeratin 7 and MUC5AC expression in Crohn's disease-associated small bowel carcinoma.

Giovanni Arpa, Alessandro Vanoli, Federica Grillo, Roberto Fiocca, Catherine Klersy, Daniela Furlan, Fausto Sessa, Sandro Ardizzone, Gianluca Sampietro, Maria Cristina Macciomei and 19 more

Open access · hybridAbstract read
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 14 institutions in 2 countries.

Giovanni ArpaUnit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Via Carlo Forlanini 16 -, 27100, Pavia, Italy.
Alessandro VanoliUnit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Via Carlo Forlanini 16 -, 27100, Pavia, Italy. alessandro.vanoli@unipv.it.ORCID http://orcid.org/0000-0002-2976-7032
Federica GrilloPathology Unit, Department of Surgical and Diagnostic Sciences, University Hospital and Ospedale Policlinico San Martino IRCCS, Genova, Italy.
Roberto FioccaPathology Unit, Department of Surgical and Diagnostic Sciences, University Hospital and Ospedale Policlinico San Martino IRCCS, Genova, Italy.
Catherine KlersyService of Clinical Epidemiology & Biometry, Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
Daniela FurlanAnatomic Pathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Fausto SessaAnatomic Pathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Sandro ArdizzoneGastroenterology, Luigi Sacco University Hospital, Milan, Italy.
Gianluca SampietroASST Rhodense, Rho Hospital, Rho, Italy.
Maria Cristina MacciomeiPathology Unit, San Camillo-Forlanini Hospital, Rome, Italy.
Gabriella NesiDivision of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Francesco TonelliDepartment of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Carlo CapellaAnatomic Pathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Giovanni LatellaGastroenterology Unit, Department of Life and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Antonio CiardiDepartment of Radiological, Oncological, Pathological Sciences, Umberto I Hospital, La Sapienza University, Rome, Italy.
Roberto CaronnaSurgical Sciences, Umberto I Hospital, La Sapienza University, Rome, Italy.
Marco Vincenzo LentiDepartment of Internal Medicine, Fondazione IRCCS San Matteo Hospital, University of Pavia, Pavia, Italy.
Rachele CiccocioppoGastroenterology Unit, Department of Medicine, AOUI Policlinico G.B. Rossi, University of Verona, Verona, Italy.
Valeria BarresiSection of Anatomical Pathology, Department of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.
Deborah MalviDepartment of Experimental, Diagnostic and Specialty Medicine (DIMES), Institute of Oncology and Transplant Pathology, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Antonietta D'ErricoDepartment of Experimental, Diagnostic and Specialty Medicine (DIMES), Institute of Oncology and Transplant Pathology, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Fernando RizzelloIntestinal Chronic Bowel Disease Unit, Department of Medical and Surgical Sciences, Sant'Orsola Malpighi Hospital, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Gilberto PoggioliSurgery of the Alimentary Tract, Department of Medical and Surgical Sciences, Sant'Orsola - Malpighi Hospital, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Claudia MescoliPathology Unit, Department of Medicine DIMED, University of Padua, Padova, Italy.
Massimo RuggePathology Unit, Department of Medicine DIMED, University of Padua, Padova, Italy.
Ombretta LuinettiUnit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Via Carlo Forlanini 16 -, 27100, Pavia, Italy.
Marco PaulliUnit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Via Carlo Forlanini 16 -, 27100, Pavia, Italy.
Antonio Di SabatinoDepartment of Internal Medicine, Fondazione IRCCS San Matteo Hospital, University of Pavia, Pavia, Italy.
Enrico SolciaUnit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Via Carlo Forlanini 16 -, 27100, Pavia, Italy.
University of Pavia · ITUniversity of Insubria · ITIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITOspedale Policlinico San Martino · ITPoliclinico Umberto I · ITUniversity of Bologna · ITUniversity of Florence · ITUniversity of Padua · ITUniversity of Verona · ITAziende Socio Sanitaria Territoriale RhodenseCarlo Forlanini Hospital · ITLuigi Sacco Hospital · ITPoliclinico San Matteo Fondazione · ITUniversity of L'Aquila · IT

Funding

Ministero della Salute 08062719
6 · The paper itself

Abstract

Most Crohn's disease-associated small bowel carcinomas (CrD-SBCs) are diagnosed in advanced stage and have poor prognosis. To improve diagnosis and therapy, a better knowledge of tumour precancerous lesions, histotypes and prognostic factors is needed. We investigated histologically and immunohistochemically 52 CrD-SBCs and 51 small bowel carcinomas unrelated to inflammatory disease, together with their tumour-associated mucosa, looking for Crohn-selective changes. Histologic patterns and phenotypic markers potentially predictive of CrD-SBC histogenesis and prognosis were analysed. Cytokeratin 7 or MUC5AC-positive metaplastic changes were found in about half of investigated CrD-SBCs, significantly more frequently than in CrD-unrelated SBCs. They correlated with metaplastic changes of their associated mucosa, while being absent in normal ileal mucosa. Histologic patterns suggestive for progression of some cytokeratin 7 and/or MUC5AC-positive metaplastic lesions into cancer of the same phenotype were also observed. Patient survival analyses showed that tumour cytokeratin 7 or MUC5AC expression and non-cohesive histotype were adverse prognostic factors at univariable analysis, while cytokeratin 7 and non-cohesive histotype were also found to predict worse survival in stage- and age-inclusive multivariable analyses. Besides conventional dysplasia, hyperplasia-like non-conventional lesions were observed in CrD-SBC-associated mucosa, with patterns suggestive for a histogenetic link with adjacent cancer. In conclusion the cytokeratin 7 and/or MUC5AC-positive metaplastic foci and the non-conventional growths may have a role in cancer histogenesis, while tumour cytokeratin 7 and non-cohesive histotype may also predict poor patient survival. Present findings are worth being considered in future prospective histogenetic and clinical studies.

Indexed as

AdenocarcinomaCarcinomaCrohn DiseaseDuodenal NeoplasmsGene ExpressionGene Expression Regulation, NeoplasticHumansIntestinal MucosaIntestine, SmallKeratin-7MetaplasiaMucin 5ACPrecancerous ConditionsPrognosisSurvival AnalysisTranscriptomeKeratin-7MUC5AC protein, humanMucin 5ACCytokeratin 7MUC5ACNon-conventional dysplasiaSmall bowel adenocarcinoma

Identifiers

PMID33963925
PMCPMC8516779
OpenAlexW3158422790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.